Scholarlink

Abstract— <p>The emergence of multidrug resistance and the urgent need for new therapeutic agents have driven the development of novel heterocyclic scaffolds with broad-spectrum bioactivity. In this study, a series of imidazo[1,2-<i>a</i>]pyrimidine–Schiff base hybrids were synthesized through a multi-step protocol starting from 2-acetylthiophene. The synthesized compounds were structurally characterized using <sup>1</sup>H NMR, <sup>13</sup>C NMR, FTIR, and mass spectrometry. Biological screening demonstrated that several derivatives exhibited promising antimicrobial, antifungal, antimalarial, and antitubercular activities. Among them, five compounds emerged as the most active candidates, one of them showed potent antifungal and antimalarial efficacy, while another one displayed notable antitubercular activity. Antimalarial assays revealed sub-micromolar IC<sub>50</sub> values (0.62–0.70 µg/mL) for the most active compounds, highlighting their strong inhibitory potential against <i>Plasmodium falciparum</i>. To complement the experimental studies, molecular docking was performed against the target protein (PDB ID: 1KZN) using AutoDock Vina. Two compounds with docking scores –8.5 kcal/mol–8.1 kcal/mol showed the highest binding affinities, supported by extensive hydrophobic interactions with key residues (ARG A:76, GLU A:50, THR A:165, ILE A:78). The docking results correlated well with experimental activity, providing mechanistic insight into the potential modes of action. Overall, the integrated biological and computational findings highlight this imidazo[1,2-<i>a</i>]pyrimidine–Schiff base series as promising scaffolds for the development of new antimicrobial, antifungal, antimalarial, and antitubercular agents. These results provide a strong foundation for further structural optimization, ADMET profiling, and in vivo validation of the most active candidates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Hybrid Imidazo[1,2-a]pyrimidine Derivatives with Thiophene and Schiff Base Linkages: Synthesis, Characterization, and Bioactivity Profiling

  • 期刊论文

  • 发表日期：

    2025年12月1日

查看全文
  • Jayesh Chopda,
  • Chandani Gori,
  • Nilesh Kanzariya,
  • Aniket Raval,
  • Viral Solanki,
  • Chandankumar Pashavan,
  • Yogesh Naliapara

摘要

Abstract—

The emergence of multidrug resistance and the urgent need for new therapeutic agents have driven the development of novel heterocyclic scaffolds with broad-spectrum bioactivity. In this study, a series of imidazo[1,2-a]pyrimidine–Schiff base hybrids were synthesized through a multi-step protocol starting from 2-acetylthiophene. The synthesized compounds were structurally characterized using 1H NMR, 13C NMR, FTIR, and mass spectrometry. Biological screening demonstrated that several derivatives exhibited promising antimicrobial, antifungal, antimalarial, and antitubercular activities. Among them, five compounds emerged as the most active candidates, one of them showed potent antifungal and antimalarial efficacy, while another one displayed notable antitubercular activity. Antimalarial assays revealed sub-micromolar IC50 values (0.62–0.70 µg/mL) for the most active compounds, highlighting their strong inhibitory potential against Plasmodium falciparum. To complement the experimental studies, molecular docking was performed against the target protein (PDB ID: 1KZN) using AutoDock Vina. Two compounds with docking scores –8.5 kcal/mol–8.1 kcal/mol showed the highest binding affinities, supported by extensive hydrophobic interactions with key residues (ARG A:76, GLU A:50, THR A:165, ILE A:78). The docking results correlated well with experimental activity, providing mechanistic insight into the potential modes of action. Overall, the integrated biological and computational findings highlight this imidazo[1,2-a]pyrimidine–Schiff base series as promising scaffolds for the development of new antimicrobial, antifungal, antimalarial, and antitubercular agents. These results provide a strong foundation for further structural optimization, ADMET profiling, and in vivo validation of the most active candidates.